BALPHARMA105.50

Bal Pharma Limited

· Pharma & Health
₹ CrorePeersALPAKREBSBIONATCAPSUQVINEETLABNECLIFEAAREYDRUGSBIOFILCHEMMANGALAMMcap ₹168 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation-15.00.00.0
+ Impairment Loss / (Reversal)0.7-15.20.0
+ Finance Costs-0.5-0.7-0.8
+ Interest Income11.03.00.0
+ Dividend Income-0.3-2.50.0
+ Fair Value (Gains) / Losses-8.6-2.10.0
+ Share-based Payments0.00.80.0
+ Unrealised FX (Gain) / Loss-2.04.30.0
+ Undistributed Profits of Associates0.70.00.0
+ Other Non-cash Items-1.60.00.0
+ Other — Cash Effects are Investing / Financing5.80.00.0
+ Other Reconciling Items10.40.00.0
Changes in Working Capital
+ Inventories-0.10.0-0.1
+ Trade Receivables — Current0.0-0.10.0
+ Trade Receivables — Non-current-1.00.20.6
+ Other Financial Assets — Current10.19.611.1
+ Other Financial Assets — Non-current0.40.00.0
+ Other Current Assets15.316.816.8
+ Other Non-current Assets-1.0-1.2-1.5
+ Other Bank Balances0.20.00.0
+ Trade Payables — Current-1.2-0.00.0
+ Other Financial Liabilities — Current-0.6-0.60.0
+ Other Financial Liabilities — Non-current1.3-3.50.0
+ Other Current Liabilities0.4-0.00.4
+ Other Non-current Liabilities10.20.00.0
+ Provisions — Current0.06.80.0
+ Provisions — Non-current1.00.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)9.05.15.96.9
+ Total Adjustments (incl. Working Capital)35.215.626.5
Cash from Operations (pre-tax)44.220.732.5
+ Interest Received — Operating270.90.0-0.0
+ Interest Paid — Operating-16.30.0-1.9
+ Dividends Received — Operating-0.70.0-13.3
+ Other Inflows / (Outflows) — Operating0.00.0-13.5
+ Income Taxes Paid1.50.0-0.3
Cash from Operating Activities329.220.77.9
Cash from Investing Activities
+ Disp of Fixed Assets0.0-4.90.0
+ Acq of Biological Assets0.015.70.0
+ Acq of Other Long-term Assets0.00.80.0
+ Purchase of Investments (Equity / Debt)0.00.00.2
+ Sale of Investments (Equity / Debt)0.00.00.4
+ Acq of Subsidiaries / Businesses (net)0.00.019.7
+ Disp of Subsidiaries / Businesses (net)0.0-18.87.3
+ Investment in Partnership Firms / LLPs0.00.70.0
+ Share of Profits — Partnership Firms / LLPs0.03.10.0
+ Loans & Advances Repaid0.0-0.70.0
+ Payments on Futures / Forwards / Options / Swaps0.0-16.80.0
+ Receipts on Futures / Forwards / Options / Swaps0.0-2.41.4
+ Government Grants Received0.01.90.0
+ Dividends Received — Investing0.04.10.9
Cash from Investing Activities0.0-18.1-9.9
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.0-3.8
+ Proceeds from Other Equity Instruments10.40.00.0
+ Proceeds from Exercise of Stock Options1.20.00.8
+ Buyback / Redemption of Own Shares-1.60.00.1
+ Payments for Other Equity Instruments0.00.00.8
+ Proceeds — Change in Ownership of Subsidiaries5.80.0-18.6
+ Payments — Change in Ownership of Subsidiaries0.00.70.0
+ Proceeds from Debentures / Notes / Bonds0.00.00.5
+ Proceeds from Borrowings-0.70.91.8
+ Repayment of Borrowings-16.30.00.0
+ Payment of Lease Liabilities0.00.03.4
+ Interest Paid0.00.05.7
+ Dividends Paid0.00.00.0
+ Income Taxes (Paid) / Refund — Financing0.00.0-1.9
Cash from Financing Activities34.60.3-27.3
Net Changes in Cash (pre-FX)363.82.9-29.3
+ Effect of FX Rate Changes on Cash0.00.00.0
Net Changes in Cash363.82.9-29.3
Closing Cash363.8
Reference Items
EBITDA31.529.631.933.8
EBITDA Margin %9.299.7510.2410.10
Free Cash Flow (CFO − Capex)329.220.77.97.9
Free Cash Flow to Equity31.511.2
Free Cash Flow per Basic Share206.7713.034.944.94
Price to Free Cash Flow21.35
Cash Flow to Net Income44.212.881.24
Cash Paid for Taxes1.50.0-0.3
Cash Paid for Interest0.00.05.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.